Washington Post Publisher Will Lewis Steps Down After Layoffs 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Instagram Outage Disrupts Thousands of U.S. Users 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Canada blocked bulk exports of prescription drugs to the US as it would cause or worsen a drug shortage at home.
The said importation from Canada is President Donald Trump's strategy of lowering some drug prices in the US, which he touted in his debate with President-elect Joe Biden.
Many Canadian drug suppliers opposed Trump's plan as it could lead to shortages,
The “Importation Prescription Drugs” rule in the US would allow licensed US pharmacists or wholesalers to import in bulk certain prescription drugs intended for the Canadian market.
According to Canada's Health Minister Patty Hajdu, companies will be required to provide information to assess existing or potential shortages, which could be as quick as within 24 hours if there is a serious or imminent health risk.
Hajdu emphasized the need for vigilance in maintaining the national drug supply noting that Canada is a small market, representing 2 percent of global drug sales, that sources 68 percent of its drugs internationally.
Canadian Prime Minister Justin Trudeau said in September that his priority was protecting the needs of Canadians in terms of pharmaceutical supplies.
